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Abstract: This study aimed to compare the phytochemicals from coffee and cocoa by-products
and their relationship with the potential for reducing markers of inflammation, oxidative stress,
adipogenesis, and insulin resistance in vitro. We characterized the phytochemical profile of extracts
from coffee husk, coffee silverskin, and cocoa shell and evaluated their in vitro biological activity
in RAW264.7 macrophages and 3T3-L1 adipocytes. Pearson correlations and principal component
regressions were performed to find the contribution of phytochemicals and underlying mechanisms
of action. Coffee husk and silverskin extracts were mainly composed of caffeine and chlorogenic acid.
Major components in cocoa shell included theobromine and protocatechuic acid. Both coffee and
cocoa by-product extracts effectively reduced inflammatory markers in macrophages and adipocytes
(NO, PGE2, TNF-α, MCP-1, and IL-6) and the production of reactive oxygen species (21.5–66.4%).
Protocatechuic and chlorogenic acids, together with caffeine, were suggested as main contributors
against inflammation and oxidative stress. Furthermore, extracts reduced lipid accumulation
(4.1–49.1%) in adipocytes by regulating lipolysis and inducing adipocyte browning. Gallic and
chlorogenic acids were associated with reduced adipogenesis, and caffeine with adipocyte browning.
Extracts from coffee and cocoa by-products also modulated the phosphorylation of insulin receptor
signaling pathway and stimulated GLUT-4 translocation (52.4–72.9%), increasing glucose uptake.
The insulin-sensitizing potential of the extracts was mainly associated with protocatechuic acid. For
the first time, we identified the phytochemicals from coffee and cocoa by-products and offered new
insights into their associations with biomarkers of inflammation, oxidative stress, adipogenesis, and
insulin resistance in vitro.
Keywords: phytochemicals; inflammation; oxidative stress; adipogenesis; insulin resistance; coffee
by-products; cocoa by-products
1. Introduction
According to the World Health Organization, chronic diseases are responsible for 71% of all
deaths worldwide [1]. About half of American adults suffer one or more chronic diseases, including
cardiovascular disease, obesity, type 2 diabetes, and cancer. These diseases could be prevented through
nutrition and adequate food patterns [2]. The disruption of cellular metabolic processes triggers energy
and redox imbalance and induces many pathophysiological conditions in the organism, designated
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as metabolic disorders [3]. The main hallmarks of metabolic disorders include insulin resistance,
glucose intolerance, dyslipidemia, and overweight. Likewise, the established chronic oxidative and
inflammatory conditions increase the risk of these diseases [4].
Obesity and the resulting metabolic disorders are linked with chronic low-grade inflammation in
the adipose tissue [5]. The adipose tissue is an organ with functions of storage, endocrine signaling,
and energy homeostasis. Being mostly composed of adipocytes, it also comprises other cell types.
Adipose tissue macrophages have been highly associated with the promotion of inflammation and
oxidative stress [6]. The promotion of a pro-inflammatory status and oxidative status in the adipose
tissue is influenced by the activation of the innate immune system [7]. The adipose tissue produces
and releases hormones and cytokines (adipokines) that display different actions on the whole body.
Adipokines can elicit the production of reactive oxygen species (ROS), triggering oxidative stress and,
consequently, an exacerbated and irregular secretion of other adipokines [8]. The contribution of
oxidative stress and mitochondrial dysfunction in cellular and tissue damage in obesity and type 2
diabetes is a hot research topic. A chronic increase in ROS and cytokine levels in adipocytes results
in mitochondrial dysfunction, which has a causative role in the attenuation of insulin signaling [9].
Likewise, excessive production of ROS may prompt an inflammatory response through the activation of
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and Jun N-terminal kinase (JNK)
pathways [10]. Inflammatory cytokines, primarily secreted by the infiltrated macrophages, induce an
exacerbated lipolysis in adipocytes. The deregulated release of free fatty acids activates inflammatory
signals in both macrophages and adipocytes, creating an inflammatory interplay between both cell
types [11].
Epidemiological and clinical studies have evidenced that dietary phytochemicals improve human
health by lowering the risk and preventing chronic diseases. Dietary phenolics are one of the most
known natural antioxidant compounds and chemopreventive agents found in food. These compounds
are associated with lower risks of obesity, diabetes, and other chronic diseases related with inflammation
and oxidative stress [12–14]. On the other hand, methylxanthines, such as caffeine and theobromine,
have been recognized as effective phytochemicals in weight control, and in the prevention of obesity
and type 2 diabetes. Caffeine increases the metabolic rate, energy expenditure, lipid oxidation, and
basal-lipolytic and thermogenic activities in the adipose tissue [15,16]. Meanwhile, theobromine has
been evidenced as a browning agent that improves lipid catabolic metabolism via the β-adrenergic and
AMP-activated protein kinase (AMPK) signaling pathway. Theobromine could exert anti-inflammatory
effects; it has demonstrated the ability to reduce cytokines in vitro, in adipocytes and macrophages [17].
Coffee and cocoa by-products, mainly coffee husk, coffee silverskin, and cocoa shell, are produced
worldwide in large amounts [18,19]. They are commonly discarded and represent a negative
impact on the environment [20,21]. Coffee and cocoa are well-recognized for their health-promoting
features [22–24]. Their by-products could be considered as potential ingredients for the food and
pharmaceutical industries [25,26]. Hence, using these by-products as sources of phytochemicals could
be a sustainable strategy in the prevention of chronic diseases. We previously evidenced the modulatory
activity of phenolics from coffee and cocoa by-products on obesity-related inflammation in adipocytes
and the alleviation of mitochondrial dysfunction and insulin resistance [27,28]. Nonetheless, the
bioactivity of extracts from coffee and cocoa by-products has not been compared, nor its association with
their phytochemical composition. Hence, this research hypothesized that the different phytochemicals
in three plant materials from coffee and cocoa by-products would be related to selected bioactivities.
We aimed to compare the phytochemicals from coffee and cocoa by-products and their relationship
with the in vitro effects for reducing markers of inflammation, oxidative stress, adipogenesis, and
insulin resistance.
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2. Materials and Methods
2.1. Materials
Dulbecco’s modified Eagle medium (DMEM) was obtained from Corning cellgro® (Manassas, VA,
USA). Newborn calf serum (NBS), fetal bovine serum (FBS), antibiotic (penicillin–streptomycin, 100×),
and 0.25% trypsin–EDTA were purchased from Gibco Life Technologies (Grand Island, NY, USA). All
additional reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated.
2.2. Preparation and Characterization of Extracts from Coffee and Cocoa By-Products
The coffee husk was provided by “Las Morenitas” (Nicaragua), the coffee silverskin, from
Colombia, by Fortaleza S.A. (Spain), both from the Arabica species, and the cocoa shell by Chocolates
Santocildes (Castrocontrigo, León, Spain). According to optimized extraction protocols, aqueous
extracts were prepared [29]. After milling and sieving, coffee husk (10 g), coffee silverskin (25 g), or
cocoa shell (10 g) were added into 500 mL of boiling water (100 ◦C) and stirred for 90 min for coffee husk
and cocoa shell, and 10 min for coffee silverskin. Coffee husk (CHE), coffee silverskin (CSE), and cocoa
shell (CAE) aqueous extracts were filtered and frozen at −20 ◦C for 24 h. Extracts were freeze-dried and
stored at −20 ◦C until further use. The analysis of targeted phenolic compounds was carried following
an ultra-performance liquid chromatography electrospray ionization-tandem mass spectrometry in
multiple reactions monitoring mode (UPLC–ESI–MS/MS) previously described [30]. Briefly, dissolved
extracts were filtered (0.22 µm), and the internal standard 4-hydroxybenzoic-2,3,5,6-d4 acid solution
(Sigma-Aldrich, St Louis, MO) (1.25 mg/mL in formic acid/acetonitrile (1:200, v/v)) was added to
the samples in a proportion 1:5 (v/v). The column employed was a BEH-C18, 2.1 × 100 mm and
1.7 µm particle size from Waters. The liquid chromatographic system was a Waters Acquity UPLC
(Milford, MA) equipped with a binary pump, an autosampler thermostatted at 10 ◦C, and a heated
column compartment (40 ◦C). The LC effluent was pumped to an Acquity TQD tandem quadrupole
mass spectrometer equipped with a Z-spray electrospray ionization (ESI) source. For quantification
purposes, data were collected in the multiple reaction monitoring (MRM) mode, tracking the transition
of the parent and product ions specific to each compound. The ESI was operated in the negative
ionization mode for the analysis of phenolics and in the positive for the analysis of methylxanthines. All
compounds were quantified using the calibration curves of their corresponding standards. Injections
were carried out in triplicate (n = 3).
2.3. Cell Cultures
The mouse RAW264.7 macrophages and 3T3-L1 preadipocytes (ATCC, Rockville, MD, USA) cell
lines were cultured in DMEM containing 10% (v/v) NBS or FBS, respectively, L-glutamine, sodium
pyruvate, and 1% (v/v) antibiotics, and maintained in a humidified atmosphere at 37 ◦C and 5% CO2.
2.3.1. Adipocyte Differentiation
The 3T3-L1 cells were cultured at a density of 6 × 103 cells cm−2 and differentiated into adipocytes
according to the protocol described by Zebisch et al. [31]. After 48 h, cell differentiation was induced
by changing the medium to 10% FBS enriched DMEM containing 0.5 mM 3-isobutyl-1-methylxanthine,
0.25 µM dexamethasone, 1 µg/mL insulin, and 2 µM rosiglitazone. After 48 h, the medium was
changed to 10% FBS enriched DMEM containing 1 µg/mL insulin for 48 h. On day 7, the medium was
changed to 10% FBS enriched DMEM and the cells were kept in this culture media until they achieve
the mature adipocyte phenotype. Cells were fully differentiated at day 10–12 and then employed for
the following experiments.
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2.3.2. Cell Viability Assay
Cell viability of macrophages, pre-adipocytes, and mature adipocytes treated with extracts
(31–500 µg/mL) was performed with the CellTiter® 96 Aqueous One Solution Proliferation assay
(Promega Corporation, Madison, WI, USA) following manufacturer’s instructions.
2.4. Anti-Inflammatory Potential
The anti-inflammatory effects of extracts from coffee and cocoa by-products were evaluated in
both RAW264.7 macrophages and 3T3-L1 mature adipocytes. Macrophages were seeded at a density
of 7 × 104 cells cm−2 and maintained 24 h in DMEM. Then, macrophages were co-treated for 24 h
with lipopolysaccharide (LPS) (1 µg/mL) and the aqueous extracts (31–500 µg/mL) simultaneously.
The conditioned media (CM) obtained after the stimulations of macrophages with LPS (1 µg/mL)
was used to develop inflammatory conditions in adipocytes. Mature adipocytes (after 10–12 days
of differentiation) were incubated for 24 h with CM and the extracts (31–500 µg/mL). Cells and their
contact media were collected and stored at −80 ◦C until analyzed.
2.4.1. Determination of Inflammatory Factors in Macrophages
NO concentration in the cell media was determined using the Griess reagent according to the
manufacturer’s protocol and using NaNO2 standard curve. Prostaglandin E2 (PGE2), tumor necrosis
alpha (TNF-α), and monocyte chemoattractant protein 1 (MCP-1) were quantified in the cell culture
media using commercially available kits following the manufacturer’s instructions (PGE2 ELISA from
Cayman Chemical (Ann Arbor, MI, USA) and TNF-α and MCP-1 ELISA kits from R&D systems
(Minneapolis, MN, USA)).
2.4.2. Assessment of Adipokines and Inflammation-Triggered Lipolysis in Adipocytes
The amount of TNF-α, MCP-1, interleukin 6 (IL-6), and adiponectin released to the medium was
determined using a Milliplex® MAP Mouse Adipocyte Luminex assay (Millipore, Billerica, MA, USA).
The culture media was used for glycerol quantification using a glycerol cell-based assay kit, and the
cell lysates were assayed for triglycerides (TAG) and lipase activity using colorimetric assay kits. All
the kits were purchased from Cayman Chemical.
2.5. Antioxidant Potential
The antioxidant activity was also evaluated in RAW264.7 macrophages and 3T3-L1 mature
adipocytes. Treatments were conducted as described in Section 2.4. In addition, RAW264.7 macrophages
(7 × 104 cells cm−2), maintained 24 h in DMEM, were stimulated for 4 h with 100 µM H2O2 and the
extracts were added simultaneously.
2.5.1. Detection of Intracellular ROS, Mitochondrial Superoxide, and Mitochondrial Membrane
Potential
After treatments, ROS were measured by incubating the cells for 1 h in DMEM with
2′,7′-dichlorofluorescein diacetate (25 µM). After washing with phosphate buffer solution (PBS),
the fluorescence was measured at an excitation/emission wavelength at 485 nm/535 nm, respectively.
Mitochondrial O2• - was detected in adipocytes with a specific fluorescent dye, Mitosox Red
(Invitrogen, Carlsbad, CA, USA) and measuring fluorescence at an excitation/emission wavelength
of 510 nm and 580 nm, respectively. Mitochondrial membrane potential (∆Ψm) was determined
using the mitochondria-specific fluorescent dye, JC-1 (Thermo Fisher, Skokie, IL, USA), according to
manufacturer’s instructions. JC1 aggregates were detected at 550/590 nm (excitation/emission), while
JC1 monomers were detected at 485/535 nm (excitation/emission). The JC1 ratio aggregates/monomers
was calculated as an indicator of mitochondrial functionality.
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2.5.2. Mitochondrial Content and Activity
In adipocytes, mitochondrial content was evaluated using Mitotracker Red (Mitotracker Deep Red
FM, Invitrogen) measuring fluorescence intensity at excitation and emission wavelengths of 644 nm
and 665 nm, respectively. Citrate synthase (CS) activity and adenosine triphosphate (ATP) content were
measured in cell lysates with commercial kits (Cayman Chemical) following the manufacturer’s protocol.
Oxygen consumption rate (OCR) was also measured using a kit according to the manufacturer’s
instructions (Abcam, Cambridge, UK).
2.6. Anti-Adipogenic Potential
3T3-L1 cells were seeded in 6-well plates and induced to differentiation in the presence of the
extracts (31–500 µg/mL) during the differentiation process.
2.6.1. Determination of Cellular Lipid Accumulation
Oil Red O (ORO) lipid staining was carried out as previously described [32]. Lipid staining was
performed at day 10–12. ORO stock solution was prepared dissolving 0.35% w/v ORO in isopropanol
overnight. Cells were fixed with formalin and a working ORO solution was added to each well. ORO
staining was eluted with 100% isopropanol and the absorbance was measured at 500 nm.
2.6.2. Assessment of Lipolysis in Adipocytes
The culture media collected from fully differentiated adipocytes after a 24 h treatment with the
extracts (31–500 µg/mL) was tested for glycerol and the cell lysates for TAG and lipase activity as
described in Section 2.4.2.
2.6.3. Evaluation of Adipocyte Brown Differentiation
To evaluate adipocyte browning, mature adipocytes differentiated in the presence of extracts were
used to measure mitochondrial content, CS activity, and ATP content as described in Section 2.5.2.
2.7. Insulin Sensitizing Potential
Insulin resistance was triggered in adipocytes by CM-stimulation, as described in Section 2.4.
2.7.1. Quantification of Glucose Uptake
The 3T3-L1 cells differentiated in a black 96-well plate with clear bottom were treated with CM and
extracts (31–500µg/mL) as indicated. After 24 h treatment, the cells were incubated for 1 h in glucose-free
DMEM with 100 µM 2-deoxy-2-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)-D-glucose. At that moment,
the cells were washed with PBS, and the fluorescence was detected at an excitation/emission wavelength
of 485 nm/535 nm.
2.7.2. Determination of GLUT4 Translocation
The 3T3-L1 cells were cultured on 8-well chambers for cell culture and immunofluorescence,
differentiated for 12 days, and treated with CM for 24 h, as previously described. Cells were cultured
overnight in low-glucose (5.5 mM) serum-free DMEM supplemented with 0.25% FBS and treated along
with the extracts (31–500 µg/mL); then, cells were starved for 4 h and stimulated with 100 nM insulin
for 30 min. Glucose transporter type 4 (GLUT4) translocation was determined, according to Luna-Vital
et al. [32]. Cells were fixed with 4% paraformaldehyde aqueous solution (Electron Microscopy Sciences)
and permeabilized with 0.1% Triton X-100 in PBS. Cells were blocked with Image-iT FX Signal Enhancer
(Life Technologies) and incubated with GLUT4 antibody overnight. Cells were washed with PBS
and incubated with Alexa Fluor 568 Goat Anti-Rabbit IgG (Life Technologies) secondary antibody
(1:200). Cells were cured with ProLong Gold antifade reagent with DAPI (Life Technologies). The
microscopy chamber plate was stored at 4 ◦C in the dark until analysis. Samples were imaged using
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a 63 × /1.4 Oil DIC M27 objective with a Zeiss LSM 880 laser-scanning confocal microscope (Carl
Zeiss AG, Germany). To evaluate GLUT4 translocation to the membrane, the fluorescence intensity, or
GLUT4 expression, was measured in the membrane of the cells and normalized using the same laser
gain (650) for all the samples. For the total GLUT4 measurement, the intensity of the whole picture
was taken in consideration and normalized to the nuclear DAPI staining.
2.7.3. Evaluation of Insulin Signaling Pathway Phosphorylation Pattern
After the 24 h treatments incubation, the cells were starved and stimulated with 10 ng/mL insulin
for an extra 30 min. Cell lysates were applied to each one of the array slides following manufacturer
instructions. An antibody array, including proteins from insulin, PI3K/AKT, AMPK, MAPK, NF-κB
signaling pathways, was used following the manufacturer instructions (Insulin Receptor Phospho
Antibody Array, Full Moon BioSystems®, Sunnyvale, CA, USA). Results were analyzed as previously
described [32]. The arrays were labeled with a Cy3-labeled streptavidin solution (0.5 mg/mL) (Sigma
Aldrich, S6402). The slides were scanned on a GenePix4000B scanner and the images were analyzed
with GenePix Pro 6.0 (Molecular Devices, Sunnivale, CA). Fluorescence signal of each array spot was
quantified; the mean values and the standard deviations of the replicates were calculated.
2.8. Bioinformatic Analysis
Functional enrichment analysis was performed using IPA v9.0 (Ingenuity® Systems). Downstream
effect analysis was performed to identify biological functions that are expected to be increased/decreased
from the observed protein phosphorylation pattern in each sample; significant predictions were
considered when biological functions presented an absolute z-score of ≥ 2 (positive indicate activation,
negative indicate inhibition). The differentially phosphorylated proteins were categorized based on
the biological process and analyzed for Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway
enrichment analysis by using the KEGG database.
2.9. Statistical Analysis
Samples were prepared in triplicate, and determinations were performed in triplicate. Results are
presented as the mean ± standard deviation (SD) (n = 3) and were analyzed by one-way analysis of
variance (ANOVA) and post hoc Tukey test. Differences were considered significant at p < 0.05 [33–35].
The statistical analysis of the results was performed using SPSS 23.0. Non-linear regressions and half
maximal effective concentration (EC50), and 30% effective concentration (EC30) values were calculated
using GraphPad Prism 7. Bi- and multivariate analyses, including Pearson correlations and principal
component regression (PCR) were performed with XLSTAT 2018 for Microsoft Excel 2016. All the
results were represented using GraphPad Prism 7.0. Pearson correlation. PCR analysis were carried
out using the concentration of each one of the compounds in the cell media after coffee husk, coffee
silverskin, and cocoa shell extracts application, as well as the values for each of the biomarkers of
inflammation, oxidative stress, adipogenesis, and insulin resistance at the respective concentration.
A non-treated cells control was also included and a concentration equal to zero for each of the
phytochemicals was assigned. PCR analysis is a regression method in two steps; first, a principal
component analysis (PCA) is carried out in the x variables (concentration of phytochemical) to reduce
the dimensionality of the data extracting the factors with the higher variation; the second step is to do
a linear regression between the sample scores on the most significant factors in x and y axes of the
PCA. This method reduced collinearity between the predictors (phytochemicals concentration), since
in a multiple linear regression model highly intercorrelated predictors may lead to an overfit model
with inflated regression coefficients and p-values. PCR method takes care of the multicollinearity by
using the principal components as new predictor variables to explain the observed variability without
considering the response variable. Only significant (p < 0.05) Pearson correlation and PCR coefficients
were discussed even if all the results were depicted as a heat map (Figure 1A and Figure S2).
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Figure 1. Heat map of the Pearson correlation coefficient established among observed in vitro effects
and the concentration of different phytochemicals in coffee and cocoa by-products (A) and the top ten
mean standardized principal component regression (PCR) coefficients of the regression constructed
among the phytochemicals identified in coffee husk, coffee silverskin, and cocoa shell aqueous extracts
and the potential of the extracts in the different biomarkers of inflammation (B), oxidative stress (C),
adipogenesis (D), and insulin resistance (E). Blue () and red () circles indicate major (one of the ten
in higher concentration) and minor phytochemicals, respectively.
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3. Results and Discussion
3.1. Coffee By-Products were Mainly Composed of Chlorogenic Acid and Caffeine whereas Cocoa Shell Primarily
Contained Methylxanthines
The phytochemical composition of coffee and cocoa by-products, namely coffee silverskin, coffee
husk, and cocoa shell was studied (Table 1).
Table 1. Phytochemical composition of coffee husk, coffee silverskin, and cocoa shell aqueous extracts
characterized by UPLC–ESI–MS/MS. Values are expressed as mean ± SD (n = 3). Different letters among
rows indicate significant differences (p < 0.05) according to ANOVA and Tukey’s multiple range test.
Compound
Concentration (µg/g Extract) Chemical
StructureCoffee Husk Coffee Silverskin Cocoa Shell
Hydroxybenzoic acids
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among rows indicate significant differences (p < 0.05) according to ANOVA and Tukey’s multiple 
range test.  
Compound 
Concentration (µg/g extract) 
Chemical structure 
Coffee husk Coffee silverskin Cocoa shell 
Hydroxybenzoic acids    
 
Gallic acid 87.0 ± 5.5c 16.9 ± 1.2a 19.2 ± 0.4b 
Protocatechuic acid 488.4 ± 26.2b 44.1 ± 3.4a 761.5 ± 47.6c 
 
4-hydroxybenzoic acid 13.4 ± 1.3b 3.4 ± 0.3a 70.1 ± 9.3c 
 
Vanillic acid 22.90 ± 9.62a 29.6 ± 0.6a N.D. 
 
Salicylic acid 3.1 ± 0.1b 2.3 ± 0.2a 3.3 ± 0.2b 
 
Hydroxycinnamic acids    
 
Caffeic acid 57.9 ± 2.0b 538.0 ± 54.3c 1.9 ± 0.2a 
Chlorogenic acid 3456.8 ± 70.6b 2791.7 ± 97.3a N.D. 
 
p-coumaric acid 8.7 ± 0.2c 0.9 ± 0.1a 4.2 ± 0.6b 
 
Ferulic acid N.D. 3.8 ± 0.2 N.D. 
 
Mandelic acids    
 
3-hydroxymandelic acid N.D. 4.4 ± 0.5 N.D. 
Mandelic acid N.D. 5.1 ± 0.2a 11.18 ± 1.2b 
 
Phenylacetic acids    
Gallic acid 87.0 ± 5.5c 16.9 ± 1.2a 19.2 ± 0.4b
Protocatechuic acid 488.4 ± 26.2b 44.1 ± 3.4a 761.5 ± 47.6c
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Vanillic acid 22.90 ± 9.62a 29.6 ± 0.6a N.D. 
 
Salicyli  acid 3.1 ± 0.1b .   .  3.3 ± 0.2b 
 
Hydroxycinnamic acids    
 
Caffeic cid 57.9 ± 2.0b 538.0 ± 54.3c 1.9 ± 0.2a 
Chlorogenic acid 3456.8 ± 70.6b 2791.7 ± 97.3a N.D. 
 
p-coumaric acid 8.7 ± 0.2c 0.9 ± 0.1a 4.2  .6b 
 
Ferulic acid N.D. 3.8 ± 0.2 N.D. 
 
Mandelic acids    
 
3-hydroxymandelic acid N.D. 4.4 ± 0.5 N.D. 
Mandelic acid . . 5.1  .2a 11.18 ± 1.2b 
 
Phenylacetic acids    
Hydroxycinnamic acids
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Phenylacetic acids    
p-coumaric acid 8.7 ± 0.2c 0.9 ± 0.1a 4.2 ± 0.6b
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3-hydr xymandel c acid N.D  4.4 ± 0.5 N.D. 
Mandelic acid N.D. 5.1 ± 0.2a 11.18 ± 1.2b 
 
Phenylacetic acids    
Ferulic acid N.D. 3.8 ± 0.2 N.D.
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3,4-dihydroxyphenylacetic acid 5.6 ± 2.0a N.D. 25.9 ± 2.4b  
4-hydroxyphenylacetic acid . . N.D. 48.5 ± 4.3 
 
Flavan-3-ols: monomers    
 
(+)-catechin 1.7 ± 0.2a 10.2  1.1b 200.8 ± 16.0c 
(−)-epicatechin 18.0 ± 2.0a N.D. 222.1 ± 13.8b 
 
Flavan-3-ols: dimers    
 Procyanidin B1 22.3 ± 2.6a N.D. 83.6 ± 7.8b 
Procyanidin B2 11.6 ± 1.8a N.D. 219.9 ± 11.4b 
 
Flavonols    
 Quercetin-3-O-galactoside 54.7 ± 0.5b N.D. 9.3 ± 0.4a 
Quercetin-3-O-glucoside 57.4 ± 3.7b N.D. 11.12 ± 0.77a 
 
Kaempferol-3-O-galactoside 122.6 ± 3.6 N.D. N.D. 
 
Alkaloids    
 
Caffeine 9815.5 ± 15.4b 19,219.2 ± 37.6c 2433.5 ± 7.8a 
Theobromine N.D. N.D. 10,035.0 ± 4.5 
 
N.D. Non-detected. 
A total of 20 phenolic compounds and two methylxanthines were identified among the three by-
products. The composition of the three by-products was different. Coffee husk and silverskin shared 
3,4-dihydroxyphenylacetic acid 5.6 ± 2.0a N.D. 25.9 ± 2.4b
4-hydroxyphenylacetic acid N.D. N.D. 48.5 ± 4.3
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Quercetin-3-O-glucoside 57.4 ± 3.7b N.D. 11.12 ± 0.77a
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Kaempferol-3-O-gal ctoside 122.6 ± 3.6 . . N.D.
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A total of 20 phenolic compounds and two methylxanthines were identified among the three
by-products. The composition of the three by-products was different. Coffee husk and silverskin shared
10 compounds, whereas a total of eight of their phytochemicals was identified in cocoa shell. Coffee
husk was mainly composed of caffeine and chlorogenic acid, also containing a significant concentration
of protocatechuic acid and flavonols, mainly kaempferol-3-O-galactoside. Previous studies also
reported similar concentrations of these compounds in coffee husk, as well as the presence of rutin [36].
Coffee silverskin presented a significantly higher (p < 0.05) concentration of caffeine (19.2 mg/g) and a
lower concentration of chlorogenic acid. This coffee by-product has been one of the most characterized
by-products, Bresciani et al. [37] demonstrated the presence of 10 different chlorogenic acids, the 3- and
5-caffeoylquinic acids being the most abundant ones. On the other hand, cocoa shell was primarily
composed of theobromine and caffeine, the main phenolics being protocatechuic acid and flavan-3-ols,
both monomers ((+)-catechin and (−)-epicatechin), and dimers (procyanidin B2). Other authors have
recently reported a similar concentration of theobromine in hydroalcoholic acidic aqueous extracts [38].
Additionally, these abovementioned polyphenols were previously shown to have different reduction
potentials, thereby exhibiting various properties in modulation of redox signaling pathways [39,40].
Given these results, it was expected that coffee and cocoa by-products, with different phytochemical
composition, would present different biological activities.
3.2. Caffeine and Phenolics in Coffee and Cocoa By-Products Reduced Inflammation in Macrophages and
Adipocytes
The aqueous extracts of coffee and cocoa by-products did not exert cytotoxicity in macrophages
nor pre-adipocytes or mature adipocytes at the tested doses (31–500 µg/mL) (Figure S1). Extracts
significantly reduced NO production (23.0–77.5%) and PGE2 (14.1–70.7%) in LPS-stimulated
macrophages (Table S1). NO and PGE2 play a key role in the development of inflammatory diseases
involved in the immune response produced by cytokine-activated macrophages [41,42]. Besides,
TNF-α (14.1–50.1%) and MCP-1 (8.0–99.4%) release were reduced by coffee and cocoa by-product
extracts. TNF-α is considered the main inflammatory stimuli in the adipose tissue while MCP-1
is involved in macrophage recruitment in adipose tissue [43]. Together, they are implicated in the
establishment of a paracrine inflammatory interaction between macrophages and adipocytes in obese
conditions [44]. As observed (Table 2), coffee husk exhibited the lowest EC30/50 for the secretion of NO,
while coffee silverskin and cocoa shell did for PGE2 and TNF-α and MCP-1, respectively.
Table 2. Anti-inflammatory effect of coffee husk, coffee silverskin, and cocoa shell extracts
(31–500µg/mL) regulating NO, PGE2, TNF-α, and MCP-1 release in lipopolysaccharide (LPS)-stimulated
RAW264.7 macrophages, and TNF-α, MCP-1, IL-6, adiponectin, intracellular triglyceride content,
extracellular glycerol release, and lipase activity conditioned media (CM)-stimulated in 3T3-L1
adipocytes. Values are expressed as mean (µg/mL) ± SD (n = 3). Different letters among rows indicate
significant differences (p < 0.05) according to ANOVA and Tukey’s multiple range test.
Biomarkers
Coffee Husk Coffee Silverskin Cocoa Shell
EC30 EC50 EC30 EC50 EC30 EC50
RAW264.7 macrophages
NO release 31.5 ± 5.0a 73.4 ± 8.9a 41.8 ± 4.4b 97.5 ± 6.5b 40.3 ± 9.8ab 94.0 ± 16.5ab
PGE2 release 134.0 ± 33.7b 312.6 ± 48.4b 58.0 ± 6.4a 135.2 ± 9.4a 118.4 ± 13.1b 276.4 ± 19.2b
TNF-α release 158.8 ± 43.2a 370.4 ± 61.7a 146.5 ± 29.5a 341.8 ± 42.8a 106.7 ± 35.7a 498.9 ± 50.3b
MCP-1 release 87.2 ± 12.1b 203.5 ± 17.7b 173.9 ± 19.7c 420.3 ± 25.0a 32.6 ± 4.7a 76.1 ± 8.6a
3T3-L1 adipocytes
TNF-α release 59.8 ± 15.3a 139.5 ± 21.9a 138.0 ± 16.5c 321.8 ± 24.1c 87.8 ± 10.4b 204.9 ± 15.2b
MCP-1 release <31.0 80.0 ± 16.6a <31.0 179.3 ± 36.8b <31.0 132.5 ± 18.8b
IL-6 release 88.2 ± 7.6a >500 233.5 ± 86.7c >500 112.5 ± 19.8b >500
Adiponectin release 96.6 ± 9.7a 225.4 ± 14.3a 95.7 ± 9.8a 232.9 ± 16.5a 115.2 ± 17.2a 268.7 ± 25.1b
Triglyceride content <31.0 60.3 ± 10.0b <31.0 32.6 ± 5.5a <31.0 <31.0
Glycerol release 77.5 ± 30.2a 265.7 ± 42.2c 68.5 ± 23.4a 187.2 ± 25.7b <31.0 26.7 ± 2.8a
Lipase activity 107.1 ± 20.5b 249.8 ± 29.7c 70.5 ± 8.2a 148.0 ± 12.3b <31.0 30.2 ± 4.4a
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These effects were mainly correlated with the concentration of salicylic acid (r > 0.72, p < 0.001)
(Figure 1). In previous studies, salicylic acid has been reported as an anti-inflammatory agent [45,46];
this well-recognized anti-inflammatory compound could reduce TNF-α and IL-6 in RAW264.7 and
THP-1 macrophages. Moreover, salicylic acid is the active bioavailable form of the well-known aspirin
(acetylsalicylic acid), a common medication used to treat inflammation [47,48].
Principal component regressions (PCR) were calculated to obtain a less biased quantitative
value (standardized PCR coefficients) of the effect of phytochemicals on the observed bioactivities
(Figure S2). Thus, we found an association of caffeine with NO, PGE2, and TNF-α release, and
correlation of caffeine and protocatechuic acid with MCP-1 production. Chlorogenic and caffeic acid
also showed a high contribution to the anti-inflammatory effects of coffee and cocoa by-products
extracts. Caffeine previously demonstrated anti-inflammatory effects in LPS-stimulated RAW264.7
macrophages, reducing inducible nitric oxide synthase (iNOS), NO, cyclooxygenase-2 (COX-2), and
IL-6 via NF-κB and p38 MAPK pathway inhibition [49]. Chlorogenic and caffeic acids have also
evidenced anti-inflammatory potential in LPS-stimulated RAW264.7 macrophages decreasing iNOS,
NO, COX-2, PGE2, and inflammatory cytokines, including IL-6, TNF-α, and MCP-1 [28,50].
Along with obesity development, the progression of adipocyte hypertrophy and adipose
tissue dysfunction evokes an exacerbated release of fatty acids, hormones, and pro-inflammatory
cytokines [51]. Here we observed that in 3T3-L1 adipocytes, the extracts abrogated the secretion of
TNF-α (8.0–66.7%), MCP-1 (37.1–71.2), IL-6 (21.0–40.1), and restored the production of adiponectin
(1.0–75.5%). Additionally, they diminished inflammation-derived lipolysis, maintaining the content
of TAG (23.3–134.3%), and reducing glycerol release (7.1–99.9%) through the inhibition of lipases
activity (8.9–99.7%). Coffee husk presented the lowest EC30/50 values for TNF-α, MCP-1, and IL-6,
whereas cocoa shell was the most potent inhibition inflammation-derived lipolysis (Table 2). Salicylic
and protocatechuic acids also correlated with the secretion of adipokines; caffeine correlated with
adiponectin production (r = 0.727, p < 0.01), and lipolysis markers were better associated with
protocatechuic acid. PCR coefficients demonstrated the contribution of p-coumaric in diminishing
MCP-1 and IL-6 releases. Chlorogenic acid exhibited a high contribution to the promotion of
adiponectin release. Salicylic acid has been shown to decrease the inflammatory interplay of
macrophages–adipocytes in CM-treated 3T3-L1 adipocytes [48]. It reduced TNF-α and IL-6 secretion
and promoted adiponectin release. Furthermore, protocatechuic acid has shown to decrease TNF-α,
MCP-1, and IL-6 in the adipose tissue both in vitro (3T3-L1 cells) and in vivo (humans) [27,52]
Meanwhile, p-coumaric acid have exhibited anti-inflammatory properties in RAW264.7 cells suppressing
COX-2, iNOS, and TNF-α expression via inhibition of NF-κB and p-38 MAPK pathways [53].
The top ten phytochemicals analyzed contributing to the anti-inflammatory properties of coffee
and cocoa by-products are shown in Figure 1B. Caffeine, chlorogenic, and caffeic acids were the 3 major
compounds showing anti-inflammatory potential, whereas salicylic, mandelic, and vanillic acids were
the minor compounds with the highest contribution.
3.3. Phenolic Compounds Reduced Oxidative Stress in Macrophages and Adipocytes and Caffeine Preserved
Adipocyte Mitochondrial Function
Obesity has been linked not only to metabolic dysfunction but also to oxidative stress. This stress
derives from inflammation, as part of the immune response of macrophages, and from mitochondrial
dysfunction, due to the excess of substrates to be oxidized [54]. Thus, together with the inflammatory
cascade triggered by LPS-stimulation, an increase of oxidative state, and a deficient mitochondrial
function were observed in macrophages. Coffee and cocoa by-products aqueous extracts significantly
(p < 0.05) scavenged ROS produced by both LPS (36.0–99.5%) and H2O2 (30.8–86.9%) stimuli (Table S2),
maintaining the ∆Ψm. Cocoa shell exhibited the highest antioxidant capacity (lowest values of EC30/50)
(Table 3). LPS-derived ROS was correlated with protocatechuic acid concentration (r = −0.710, p < 0.01)
as well as H2O2-derived ROS (r = −0.571, p < 0.05). The recovery of ∆Ψm upon both stimuli was
significantly associated with mandelic and p-coumaric acid concentration (r = 0.802, p < 0.001 and
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r = 0.644, p < 0.01, respectively). PCR coefficient denoted the contribution of caffeic and chlorogenic
acids on the prevention of ∆Ψm loss with LPS and H2O2 treatments, respectively. Furthermore, in
adipocytes, the extracts reduced ROS (21.5–66.4%) and particularly mitochondrial O2• - (18.1–52.6%).
The loss of ∆Ψm was arrested by 11.0–96.6%. Coffee husk showed the lowest EC30/50 values for ROS
production in adipocytes (Table 3).
Table 3. Protective effect of coffee husk, coffee silverskin, and cocoa shell extracts (31–500 µg/mL) against
oxidative stress and mitochondrial dysfunction regulating ROS and ∆Ψm in RAW264.7 macrophages
and ROS, mitochondrial O2• -, ∆Ψm, mitochondrial content, citrate synthase (CS) activity, oxygen
consumption rate (OCR), and ATP content in 3T3-L1 adipocytes. Values are expressed as mean
(µg/mL) ± SD (n = 3). Different letters among rows indicate significant differences (p < 0.05) according
to ANOVA and Tukey’s multiple range test.
Biomarkers
Coffee Husk Coffee Silverskin Cocoa Shell
EC30 EC50 EC30 EC50 EC30 EC50
RAW264.7 macrophages
ROS (LPS) <31.0 48.2 ± 2.4b <31.0 69.5 ± 6.6c <31.0 34.7 ± 2.7a
∆Ψm (LPS) >500 >500 167.7 ± 22.6a 391.3 ± 33.0a 143.5 ± 36.9a 334.9 ± 52.8a
ROS (H2O2) 51.7 ± 9.3 120.7 ± 13.5c <31.0 71.7 ± 3.2b <31.0 46.6 ± 3.5a
∆Ψm (H2O2) <31.0 33.6 ± 3.7a 32.4 ± 3.5a 75.6 ± 6.6b 41.9 ± 8.6a 97.8 ± 12.4c
3T3-L1 adipocytes
ROS 54.8 ± 10.5a 128.1 ± 15.2a 150.2 ± 39.7c 350.6 ± 56.9b 82.4 ± 16.1b 192.3 ± 23.4a
Mitochondrial O2• - 86.4 ± 24.5a 201.6 ± 35.0a 207.8 ± 57.2b >500 94.8 ± 28.5a 221.2 ± 40.4a
∆Ψm 140.9 ± 14.8c 336.0 ± 12.5b 58.0 ± 6.3a 135.3 ± 9.2a 94.8 ± 18.5b 161.5 ± 22.9a
Mitochondrial content 40.2 ± 7.6 96.0 ± 8.6b <31.0 43.2 ± 6.8a <31.0 74.9 ± 12.1b
CS activity <31.0 <31.0 <31.0 <31.0 <31.0 <31.0
OCR 399.0 ± 66.1b >500 125.01 ± 23.5a 291.8 ± 34.0a 158.11 ± 24.6a 368.8 ± 35.9b
ATP content 80.7 ± 11.3b 188.2 ± 16.5c <31.0 59.4 ± 7.6a 39.4 ± 8.3a 91.9 ± 14.3b
ROS inhibition was correlated with protocatechuic and p-coumaric acids (r = −0.716, p < 0.01
and r = −0.779, p < 0.001, respectively). Mitochondrial O2• - followed the same behavior. ∆Ψm was
correlated with the concentration of mandelic acids (r = −0.787, p < 0.001). Moreover, PCR showed
a high contribution of p-coumaric and gallic acid in the attenuation of ROS and O2• - in adipocytes,
whereas ∆Ψm was associated with the concentration of caffeine and caffeic acid. Protocatechuic acid has
evidenced its potent antioxidant properties in vitro and in vivo [55]. In macrophages, protocatechuic
acid up-regulated enzymatic antioxidant defenses through JNK-mediated Nrf2 activation [56]. Likewise,
caffeic acid previously has exhibited protective effects against mitochondrial oxidative stress, scavenging
H2O2 [57], and preserving glutathione levels upon tert-butyl hydroperoxide-induced oxidative stress
in HepG2 cells [58]. Additionally, caffeine has demonstrated to possess ROS scavenging properties
and capacity to maintain ∆Ψm [59].
The loss of mitochondrial function derived from an inflammatory and oxidative environment has
been associated with increased insulin resistance in the adipose tissue [60]. Here, treating adipocytes
with coffee and cocoa by-products preserved mitochondrial content (12.1–144.8%) and activity, measured
as CS activity (75.6–150.8%), OCR (0.6–66.5%), and the production of ATP (11.4–108.3%) (Table S2).
Coffee silverskin was the significantly (p < 0.05) most potent treatment in the conservation of
mitochondrial content and activity, exhibiting EC30/50 values lower than 31 µg/mL except for OCR
(125 µg/mL) (Table 3). These effects were associated with the concentration of caffeine (r ≥ 0.563,
p < 0.05). Protocatechuic acid was linked to the protection of mitochondrial content (r = 0.571, p < 0.05);
caffeic acid was associated with OCR (r = 0.626, p < 0.01); and mandelic acid with OCR and ATP
content (r ≥ 0.746, p < 0.01). PCR highlighted the contribution of caffeic acid and caffeine in the
preservation of mitochondrial content and activity (CS, activity, OCR, and ATP content). Protocatechuic
acid has proved potential on mitochondrial function in vitro and in vivo, preventing derived cell
apoptosis [61,62]. Caffeic acid has displayed protective effects on mitochondrial function under
oxidative stress conditions via activation of Nrf2 [58]. Furthermore, the effects of caffeine have been
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investigated; this methylxanthine exhibited the ability to increase OCR and ATP production in mice
brain [59].
The top ten compounds analyzed ordered by contribution to the preventive properties of coffee
and cocoa by-products against oxidative stress and mitochondrial dysfunction are shown in Figure 1C.
Again, caffeine, and chlorogenic and caffeic acids were the three compounds identified in a higher
concentration that exhibited the best antioxidant properties. On the other hand, salicylic, vanillic, and
ferulic acids were the minor compounds with the highest contribution.
3.4. Caffeine and Phenolics in Coffee and Cocoa By-Products Attenuated Adipogenesis and Promoted
Adipocyte Browning
Besides favoring inflammatory and oxidative processes, the adipose tissue continues expanding
in energy imbalance conditions (high caloric diets and reduced physical activity). Reducing lipid
accumulation and promoting lipolysis in the first stages of adipose tissue expansion can be considered
to be anti-adipogenic strategies [63]. Extracts from coffee and cocoa by-products reduced lipid
accumulation (4.1–44.5%) (Table S3). The lowest (p < 0.05) EC30/50 value was that of coffee husk
(Table 4). This lipid-reducing effect may be either owing to cell proliferation or the inhibition of the
preadipocyte differentiation (adipogenesis) [63]. This effect mainly correlated with the concentration
of gallic, chlorogenic, and p-coumaric acids (r = −0.870, −0.843, and −0.843, respectively, p < 0.0001).
PCR analysis supported those results. Gallic acid proved to have anti-adipogenic activity in 3T3-L1
adipocytes by inhibiting Pparγ, Scd-1, and Fasn expression [64]. Besides exerting these effects,
p-coumaric acid was able to down-regulate the expression of the transcription factor CEBPα, Lpl,
AdipoQ, and Fabp4. Additionally, chlorogenic acid reduced lipid accumulation via Plin1 and Srebp1
down-regulation. The impact of the coffee and cocoa by-products extracts on lipogenesis/lipolysis in
mature adipocytes was further assessed, and the results are shown in Table 4 and Table S3. Extracts
reduced TAG content by 11.9–63.0% via lipolysis stimulation, enhancing glycerol release (0.4 to 3.2-fold)
and lipase activity (6.5–45.6%). Coffee silverskin was found to be the most effective treatment exhibiting
the lowest EC30/50 values. The effect in glycerol significantly correlated with the content of vanillic
and chlorogenic acids (r = 0.908 and 0.845, respectively, p < 0.0001) and the concentration of caffeine
(r = 0.899, p < 0.0001); similarly, these compounds correlated with the activation of lipases activity.
Both the Pearson correlation and PCR analysis revealed the contribution of caffeic acid. Vanillic acid
presented a strong effect reducing TAG content in 3T3-L1 adipocytes through the reduction of AdipoQ,
Plin1, and Fabp4 expression [64]. Chlorogenic acid has shown to increase lipolysis and up-regulate the
expression of lipases (Hsl and Dgat1) [65,66]. Similarly, caffeine has exhibited potential to up-regulate
HSL and AGTL and increase lipolysis, reducing TAG content in 3T3-L1 cells [67,68].
Table 4. Anti-adipogenic effect of coffee husk, coffee silverskin, and cocoa shell extracts (31–500 µg/mL)
modulating lipid accumulation, intracellular triglyceride content, extracellular glycerol release, lipase
activity, mitochondrial content, citrate synthase (CS) activity, and ATP content in 3T3-L1 adipocytes.
Values are expressed as mean (µg/mL) ± SD (n = 3). Different letters among rows indicate significant
differences (p < 0.05) according to ANOVA and Tukey’s multiple range test.
Biomarkers
Coffee Husk Coffee Silverskin Cocoa Shell
EC30 EC50 EC30 EC50 EC30 EC50
Lipid accumulation 132.7 ± 18.1a 309.6 ± 23.8a 220.8 ± 35.1b 515.3 ± 46.1b 388.1 ± 67.4c 905.5 ± 88.4c
Triglyceride content 64.9 ± 12.4a 151.5 ± 30.5b 49.6 ± 17.5a 115.7 ± 22.3a 353.1 ± 64.5b 823.8 ± 146.7c
Glycerol release <31.0 <31.0 <31.0 <31.0 36.8 ± 8.4 85.9 ± 4.3
Lipase activity 357.3 ± 73.8b 833.6 ± 106.7b 210.9 ± 33.4a 492.1 ± 48.6a 422.2 ± 57.6b 985.2 ± 142.9b
Mitochondrial content >500 >500 >500 >500 >500 >500
CS activity 227.6 ± 43.1b 531.1 ± 62.4b 140.9 ± 22.8a 328.9 ± 33.2a 247.4 ± 51.4b 577.2 ± 74.3b
ATP content >500 >500 251.8 ± 24.0a 587.5 ± 35.2a 312.4 ± 44.6b 728.9 ± 65.1b
Furthermore, it has been shown that during differentiation, adipocytes can acquire a brown-like
or beige phenotype, a process known as adipocyte browning. These beige adipocytes exhibit higher
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mitochondrial content and activity [69,70]. Thus, coffee and cocoa by-products increased (1.0–26.6%)
the mitochondrial content as well as increased mitochondrial citrate synthase activity by 9.0–54.5%;
the production of ATP was also increased (2.9–48.0%). The lowest EC30/50 values were shown for
coffee silverskin treatment (Table 4). The increase in mitochondrial content was associated with
the concentration of salicylic and mandelic acids in the extracts (r = 0.831 and 0.735, respectively,
p < 0.001). However, the promotion of mitochondrial CS activity and the production of ATP better
correlated with the content of salicylic acid and caffeine (r = 0.789 and 0.774, respectively, p < 0.001).
Nonetheless, the contribution of caffeic acid, beyond caffeine, was demonstrated by PCR analysis.
The browning effects of salicylic acid has been associated with its capacity to increase Ucp1, Pparα,
and Elovl3 expression [71]. The effects of caffeine on adipocyte browning have been intensely studied.
Caffeine prompts mitochondrial biogenesis and UCP1 expression, increasing the oxidative capacity
of mitochondria and ATP production, via PGC-1α pathway activation, and evidencing enhanced
thermogenesis in humans [72,73]. Likewise, caffeic acid has been suggested to be able to increase
mitochondrial content and prompt its oxidative activity in adipocytes [28]. The use of nutritional
interventions, natural products, and phytochemicals to stimulate mitochondrial biogenesis and
bioenergetics and attenuate oxidative stress are current strategies for the prevention and treatments of
chronic metabolic disorders [74].
The ten compounds with the highest potential to inhibit adipogenesis and elicit adipocyte browning
are described in Figure 1D. Caffeine, chlorogenic, and caffeic acids were the main contributor among
those phytochemicals identified in higher concentration in coffee and cocoa by-products. Vanillic,
3-hydroxymandelic, and ferulic acids were the minor compounds exhibiting the highest contribution.
3.5. Phenolic Compounds Counteracted Insulin Resistance through the Modulation of Insulin Signaling and the
Promotion of GLUT4 Translocation
Upon insulin binding with its receptor, a sequence of reactions conduces to GLUT4 translocation
into the membrane and the subsequent glucose uptake. In obese conditions, inflammation derives in
insulin resistance, which is associated with the development of type 2 diabetes [75,76]. The extracts
from coffee and cocoa by-products counteracted the inhibition of insulin signal transduction via
modulation of the phosphorylation of key proteins in the insulin pathway (Figure 2). From a total of
30 protein involved in the insulin receptor signaling pathway, 20 protein were up-phosphorylated and
10 down-phosphorylated. CHE and CAE promoted INSR tyrosine phosphorylation. CSE and CAE
potentiated PI3K phosphorylation (52.8–201.2%). That resulted in augmented AKT phosphorylation
(from 16.9 to 316.5%). Lately, extracts prompted PKC ζ phosphorylation (9.9–67.8%), which would
result in GLUT 4 translocation into the cell membrane [77]. Furthermore, extracts inhibit the action of
diverse phosphatases (PTEN, PP1α, and PP2A) through their phosphorylation (from 1.4 to 14.8-fold).
IRS-1 was down-phosphorylated by at least one of the extracts in six different serine residues, which
promoted insulin signaling. As a result, GLUT4 was significantly (p < 0.05) more translocated to the
membrane (59.8–79.3%) and glucose uptake stimulated (75.4–80.4%) in comparison to the non-treated
control. INRS phosphorylation was associated with the content of protocatechuic acid and theobromine
(r = 0.763 and 0.833, respectively, p < 0.001). PCR denoted the contribution of (+)-catechin. Likewise, the
phosphorylation of PI3K correlated with the concentration of (+)-catechin and theobromine (r = 0.818
and 0.817, respectively, p < 0.001). AKT phosphorylation, in its different residues, correlated with
protocatechuic acid and procyanidin B1 (T308), theobromine and caffeine (S326 and S473, respectively),
chlorogenic acid and caffeine (S124), theobromine (S246), (+)-catechin, (−)-epicatechin, procyanidin B2
(Y474), and protocatechuic acid (T72). PCR exhibited a significant contribution in the phosphorylation
of AKT of protocatechuic acid and procyanidin B1 (Y326) and corroborated the results obtained using
Pearson correlations. PKC ζ phosphorylation was associated with protocatechuic and p-coumaric
acids (T410 and T560). PTEN exhibited an association with chlorogenic (S380), gallic acid, and
kaempferol-3-O-galactoside (S382). Similar behavior demonstrated PP1α and PP2A. Moreover, the
results from PCR analysis gave similar information on the contribution of those phytochemicals.
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The down-phosphorylation of IRS-1 mainly correlated with the concentration of protocatechuic and
caffeic acids, caffeine, and theobromine. GLUT4 translocation correlated with the concentration of
protocatechuic and gallic acids (r = 0.699 and 0.642, respectively, p < 0.01). Glucose uptake was
associated with the concentration of protocatechuic acid (r = 0.746, p < 0.001). The contribution of
p-coumaric acid was also significant, as observed in both the Pearson correlation and PCR coefficients.Antioxidants 2019, 8, x FOR PEER REVIEW 15 of 23 
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Protocatechuic acid possesses insulin-mimicking both in vitro and in vivo. Engaging the INSR
and including a reversion of INS-1 serine phosphorylation, and activation of insulin/PI3K/AKT and
AMPK signaling pathways, protocatechuic acid triggers a positive regulation of and glucose uptake
through GLUT4 translocation [78]. Likewise, gallic acid induces GLUT4 translocation and glucose
uptake activity in 3T3-L1 cells via PKC ζ activation [79]. Insulin resistance is strongly associated with
the pathogenesis of type 2 diabetes and obesity and results from a sustained low-grade inflammatory
status and the loss of the mitochondrial function [80]. Hence, the alleviation of these conditions and the
modulation of insulin sensitivity are needed in the prevention of the development and exacerbation of
obesity and diabetes outcomes.
The top ten phytochemicals analyzed from coffee and cocoa by-products with the highest potential
to prevent insulin resistance development are included in Figure 1E. Protocatechuic acid, (−)-epicatechin,
and procyanidin B2 were the major compounds contributing to these effects. Procyanidin B1, p-coumaric
and 3,4-dihydroxyphenilacetic acids, in turn, the minor compounds exhibiting the highest contribution.
3.6. Phytochemicals from Coffee and Cocoa By-Products Regulated Protein Phosphorylation thereby Preventing
Inflammation, Oxidative Stress, and Insulin Resistance
Beyond modifying the phosphorylation of proteins in the insulin receptor pathway, coffee and
cocoa by-product aqueous extracts modulated the phosphorylation state of proteins associated with
pathways related to inflammation and oxidative stress (Figure 3). Coffee husk significantly (p < 0.05)
modulated the phosphorylation of 82 out of 122 (67%) phosphorylation sites evaluated, whereas coffee
silverskin modified 76 and cocoa shell 84 (62 and 69%, respectively) (Figure 3A; Table S3). Among the
three treatments, the phosphorylation pattern was different. They shared 51–58 phosphorylation sites
when comparing among pairs, and only 37 phosphorylation sites were modulated by all the treatments.
Among the top pathways accounting with modified proteins, the most significant ones were insulin,
mTOR, PI3K-AKT, FOXO, and AMPK signaling pathways (Figure 3B).
Downstream effect analysis validated the effects analyzed in adipocytes for inflammation, oxidative
stress, and insulin resistance (Figure 3C–F). The inflammatory response in adipocytes was mediated
by the phosphorylation of proteins from the TNF-α (TNFR1, TNFR 2), NF-κB (IKKβ, IKKγ), and
MAPK (MEK1, MEK2, ERK1) pathways, among others (Figure 3C). Lipid accumulation and lipolysis
in inflammatory conditions were regulated by the modulation of the phosphorylation of proteins
related to the insulin (INSR, IRS-1, PI3K, AKT, FOXO) and the TNF-α (TNFR, IKKβ, iNOS) signaling
pathways and HSL (Figure 3D). Inflammation in the adipose tissue causes lipolysis and the release of
free fatty acids, serving as ligands for toll-like receptor-4 (TLR4) and further activating NF-κB and JNK,
leading mediators of inflammation [81]. Thus, the reduction of inflammation in adipocytes results
in lower lipolysis (higher accumulation of lipid) through the maintaining of insulin sensitivity. As
observed in Figure 2B, the main compounds identified in coffee and cocoa by-products responsible for
the anti-inflammatory properties were caffeine, caffeic, chlorogenic, and protocatechuic acids.
Furthermore, the phosphorylation of proteins from insulin (INSR, PI3K, AKT), PKC (PKC ζ,
PKC θ), and mTOR (mTOR, p70S6K) pathways was predicted to be affecting the production of ROS
and specifically the production of mitochondrial superoxide (Figure 3E). The main phytochemicals
contributing to these effects were also caffeine, caffeic, chlorogenic, and protocatechuic acids. It has
been reported that mTOR, a downstream of the insulin/PI3K/AKT pathway, depending upon PKC, can
be conducive to defective ROS production [82]. Most of these proteins were modulated by both coffee
and cocoa by-products. Therefore, the production of ROS and mitochondrial superoxide was repressed.
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upon the treatment with coffee husk, coffee silverskin, and cocoa shell aqueous extracts (31–500 µg/mL)
(A). KEGG pathways associated with the differentially phosphorylated r teins (B). Downstream effect
analysis of coffee and cocoa extra ts on i flammato y respo se (C), lipid t rage and lipolysis (D),
oxidative stress (E), and insulin resi tance (F).
On the other hand, the most important compounds contributing to the anti-adipogenic properties
of coffee and cocoa by-products were caffeine, and chlorogenic and gallic acids. Finally, the modification
of the phosphorylation state of proteins in insulin (INSR, IRS-1, AKT), AMPK (PKA), TNF-α (TNFR1,
TNFR 2), and NF-κB (IKKβ, IKKγ) signaling pathways triggered an increase in insulin sensitivity in
adipocytes in inflammatory conditions (Figure 3F). Among the pro-inflammatory stimuli secreted by
macrophages, TNF-α presence proved evidence of conducting insulin resistance through the IRS-1
serine phosphorylation, and inactivation, via activation of NF-κB, ERK, JNK, mTOR, and PKC θ [83].
We might attribute these effects to protocatechuic acid, (−)-epicatechin, and procyanidin B2.
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Hence, coffee husk, coffee silverskin, and cocoa shell mediated alleviation of inflammatory
processes could also reverse inflammation-triggered oxidative stress, mitochondrial dysfunction, and
insulin resistance.
A diagram illustrating the mechanism and main actors of the effects in macrophages and adipocytes
is shown in Figure 4. As described, the phytochemicals exerting most of the biological effects associated
with inflammation, oxidative stress, adipogenesis, and insulin resistance were caffeine, chlorogenic,
and protocatechuic acids.
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In this comparative study, we have observed that the differential composition of coffee and cocoa
by-products is associ ted with their in vitro biological properties. Both major and minor components
of coffee husk, coffee silverskin, and cocoa shell presented a relationship with the potenti l against
inflammation, xidative stress, adipogen sis, and insulin resistance. Comparing the effects of coffee
husk, coffee silverskin, and c coa shell, we observed (Figure S3) that the best extra t for preve ting
inflammation was that of cocoa shell. Results suggest that oxidative stress was prevent d by cocoa
shell and coffee silverskin, where s the anti-adipogenic potential was stronger for coffe silverskin.
The ability to counteract insulin resistance was higher for coffee husk. Despite the potential biological
activity of phytochemicals identified in coffee and cocoa by-products, p enolic compound bioefficacy
is conditioned y their low bioavailability. These phytochemicals are only partially absorbed in
the gastrointestinal tract. After being metabolized by the microbiota or in the liver (methyl tion,
sulfation, and glucuronidation), they reach target tissues at low concentrations [71,72]. Future in vivo
studies with coffee and cocoa by-products will allow us to ascertain their pharmac kinetic beh vi r
and their efficacy in delaying the devel pment of met bolic disorders rel ted to inflammatio and
oxidative stress.
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4. Conclusions
The use of coffee and cocoa by-products as a source of phytochemicals is proposed as a strategy
in the prevention of chronic diseases related to inflammation and oxidative stress, such as obesity
and diabetes. This study presents an evaluation of the chemical composition of coffee husk, coffee
silverskin, and cocoa shell in the inhibition of inflammation, oxidative stress, adipogenesis, and
insulin resistance using RAW264.7 macrophages and 3T3-L1 adipocytes. Taken together, our results
support the notion that phenolic compounds and methylxanthines from coffee and cocoa by-products
can trigger an attenuation of inflammation and oxidative stress in macrophages and adipocytes,
counteracting the consequent loss of mitochondrial function, as well as reduce adipogenesis and
induce browning in adipocytes, and potentiating insulin sensitivity. Furthermore, we provide new
knowledge on the underlying mechanism of action and contribution of the phytochemicals composing
coffee husk, coffee silverskin, and cocoa shell. This research revalorizes by-products from coffee and
cocoa, therefore, increasing their potential utilization and their conversion into food ingredients, with
the added-value potential to prevent chronic metabolic diseases. Additionally, in the future, in vivo
studies will be accomplished to validate the safety and efficacy of coffee and cocoa by-products as new
ingredients. In conclusion, we established, for the first time, the relationship of the composition of
different phytochemicals among coffee and cocoa by-products and their in vitro potential to reduce
markers of inflammation, oxidative stress, adipogenesis, and insulin resistance.
Supplementary Materials: The following are available on line at http://www.mdpi.com/2076-3921/8/8/279/s1,
Figure S1: Impact of treatments on cell viability of (A) RAW264.7 macrophages, (B) 3T3-L1 preadipocytes, and (C)
3T3-L1 differentiated adipocytes. Cells were treated in the absence (NT) or presence of coffee husk, coffee silverskin,
or cocoa shell aqueous extracts (31–500 µg/mL) for 24 h, after which the cell viability was determined using an
MTS colorimetric assay. The results are expressed as mean ± SD (n = 3). NT: non-treated cells; Figure S2: Heat map
including standardized principal component regression (PCR) coefficient of the regression constructed among the
phytochemicals identified in coffee husk, coffee silverskin, and cocoa shell aqueous extracts and the potential of
the extracts in the different biomarkers of inflammation, oxidative stress, adipogenesis, and insulin resistance;
Figure S3: Dendrograms of hierarchical cluster analysis of the treatments of coffee husk (CHE), coffee silverskin
(CSE), and cocoa shell (CAE) on the different in vitro models od inflammation, oxidative stress, adipogenesis,
and insulin resistance. All the variables in each group of biological activity were included. NT: non-treated cells;
Table S1: Anti-inflammatory effect of coffee husk, coffee silverskin, and cocoa shell extracts regulating NO, PGE2,
TNF-α, and MCP-1 release in LPS-stimulated RAW264.7 macrophages, and TNF-α, MCP-1, IL-6, adiponectin,
intracellular triglyceride content, extracellular glycerol release, and lipase activity CM-stimulated in 3T3-L1
adipocytes. Values are expressed as mean ± SD (n = 3). Different letters among rows (same concentration) indicate
significant differences (p < 0.05) according to ANOVA and Tukey’s multiple range test; Table S2: Protective effect
of coffee husk, coffee silverskin, and cocoa shell extracts against oxidative stress and mitochondrial dysfunction
regulating ROS and ∆Ψm in RAW264.7 macrophages and ROS, mitochondrial O2• -, ∆Ψm, mitochondrial content,
citrate synthase activity, OCR, and ATP content in 3T3-L1 adipocytes. Values are expressed as mean ± SD (n = 3).
Different letters among rows (same concentration) indicate significant differences (p < 0.05) according to ANOVA
and Tukey’s multiple range test; Table S3: Anti-adipogenic effect of coffee husk, coffee silverskin, and cocoa
shell extracts modulating lipid accumulation, intracellular triglyceride content, extracellular glycerol release,
lipase activity, mitochondrial content, citrate synthase activity, and ATP content in 3T3-L1 adipocytes. Values are
expressed as mean ± SD (n = 3). Different letters among rows indicate significant differences (p < 0.05) according
to ANOVA and Tukey’s multiple range test; Table S4: Significantly (p < 0.05) up- and down-phosphorylated
proteins, expressed as log2 (Fold Change), in insulin-resistant 3T3-L1 cells in response to treatment with extracts
from coffee husk, coffee silverskin, and cocoa shell.
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